Children with congenital heart disease require periodic neurodevelopmental surveillance and screening to identify deficits and facilitate early therapeutic interventions for improved long-term outcomes.
Children with CHD are at increased risk of developmental disorder or disabilities or developmental delay. Periodic developmental surveillance, screening, evaluation, and reevaluation throughout childhood may enhance identification of significant deficits, allowing for appropriate therapies and education to enhance later academic, behavioral, psychosocial, and adaptive functioning.
Marino et al. (Tue,) studied this question.